ArticleJournal of thoracic disease2025
Evaluating non-contrast 3D reconstructions for pulmonary segmentectomy: a reliable alternative to contrast-enhanced models in thoracic surgery.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Thoracoscopic segmentectomy is increasingly used to treat early-stage non-small cell lung cancer (NSCLC) due to its ability to preserve pulmonary function and maintain quality of life. Preoperative three-dimensional (3D) reconstructions are essential for planning this procedure, particularly for identifying anatomical variations and ensuring precise resections. While intravenous (contrast-enhanced) (IV) 3D models are the gold standard, they are associated with risks such as allergic reactions, renal impairment, and logistical challenges. The aim of this study was to evaluate whether non-intravenous (non-contrast imaging) (NIV) 3D models can provide an anatomically reliable alternative to IV-based models for preoperative planning in pulmonary segmentectomy. Methods: This mixed-designed study with prospective enrollment and retrospective data analysis evaluated the anatomical equivalence of NIV 3D models by Visible Patient compared to IV-based models in 24 patients scheduled for pulmonary segmentectomy. Postoperative analysis assessed concordance between the models and intraoperative findings, focusing on the impact of any discrepancies on surgical decision-making. Results: NIV models demonstrated an 83.3% concordance rate with IV models for major anatomical structures, including significant vascular and bronchial variations. Minor differences, primarily involving small intraparenchymal vessels, were observed in 16.7% of cases but had no impact on surgical strategy. Both models reliably identified complex variants, such as mediastinal lingular arteries, highlighting the clinical utility of NIV reconstructions. Conclusions: NIV 3D models by Visible Patient offer a reliable alternative for preoperative planning, particularly in patients contraindicated for contrast agents. While IV models remain the gold standard, NIV models address critical challenges, including contrast-related risks and logistical inefficiencies, supporting their integration into routine thoracic surgical practice. Further multicenter validation is recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.